Researchers have identified how a specific gene protects dopamine-producing neurons from dying in both animal models and in cultures of human neurons.

Parkinson’s disease researchers have discovered how mutations in the parkin gene cause the disease, which afflicts at least 500,000 Americans and for which there is no cure.

In the US alone, at least 500,000 people suffer from Parkinson's disease, a neurological disorder that affects a person's ability to control his or her movement. New technology lets researchers observe the development of the brain cells responsible for the disease.

Scientists have identified a protein that exacerbates symptoms of Parkinson's disease -- a discovery that could one day lead to new treatments for people who suffer from this devastating neurodegenerative illness.

Scientists have made a significant step forward in isolating the cause of Parkinson’s disease in younger adults.

Deep brain stimulation -- also known as DBS -- is effective at improving motor symptoms and quality of life in patients with advanced Parkinson's disease, according to new research.

Demographics and clinical factors appear to be associated with survival in patients with Parkinson's disease, and the presence of dementia is associated with a significant increase in mortality, according to a new report.

In efforts to find new treatments for Parkinson's Disease (PD), researchers have directly reprogrammed astrocytes, the most plentiful cell type in the central nervous system, into dopamine-producing neurons. PD is marked by the degeneration of dopaminergic neurons in the midbrain.

Atrophy in the hippocampus, the region of the brain known for memory formation and storage, is evident in Parkinson's disease patients with cognitive impairment, including early decline known as mild cognitive impairment, according to a new study.

A method of classifying brain atrophy patterns in Alzheimer's disease patients using MRIs can also detect cognitive decline in Parkinson's disease, according to a new study. Researchers also found that higher baseline Alzheimer's patterns of atrophy predicted long-term cognitive decline in cognitively normal Parkinson's patients. The study is published online ...

One of the problems affecting the human nervous system is dopamine deficiency. But testing of dopamine concentration is costly and requires sophisticated equipment not available in a doctor's office. Enter a team of Polish scientists who developed a method enabling the detection of dopamine in solutions both easily and cheaply, ...

Researchers have devised a simple test, using dopamine-deficient worms, for identifying drugs that may help people with Parkinson's disease.